Mark Y. Liberman is the Christopher H. Browne Distinguished Professor of Linguistics and Trustee Professor at the University of Pennsylvania. He holds a joint appointment in the Department of Linguistics and the Department of Computer and Information Science. His roles include Director of the Linguistic Data Consortium (LDC), Faculty Director of Ware College House, and former Director of the Institute for Research in Cognitive Science. Education: A.B. in Linguistics and Applied Mathematics from Harvard University (1965–1969), M.S. (1972) and Ph.D. (1975) in Linguistics from MIT. Research focuses on corpus-based phonetics, clinical linguistics applications, tonal phonology, formal models for linguistic annotation, and computational linguistics. He explores speech production, prosody, and interdisciplinary topics like language evolution and neurobiology of speech. Recent articles highlight advancements in speech biomarkers for neurodegenerative diseases, autism analysis, and computational linguistics. Awards include Fellowships from the AAAS and Linguistic Society of America. He advises graduate students and leads large-scale language resource initiatives like LDC, contributing to open-access linguistic datasets. Labs/Teams: Linguistic Data Consortium (LDC), Institute for Research in Cognitive Science (IRCS), and collaborations in computational linguistics and neuroscience.
Professor Hutan Ashrafian is a clinician-scientist and surgeon at the University of Leeds Business School, holding dual roles as Professor of Research Impact and Senior Research Fellow at Imperial College London. His expertise spans AI in healthcare, metabolic surgery, and ancient history. He pioneered STARD-AI and QUADAS-AI guidelines for AI diagnostics, collaborated on AI-driven breast cancer screening with Google and NHS, and led global health policy initiatives. Ashrafian’s work bridges medicine, history, and philosophy, including his contributions to understanding historical figures’ medical conditions, such as King Tutankhamun’s epilepsy. He has authored over 550 publications, 12 books, and holds a PhD in computational physiology and an MBA with distinction. Awards include the Hunterian Prize and Wellcome Trust Fellowship. His research also explores AI ethics, quantum physics paradoxes, and art-based medical diagnostics. Education: PhD in Computational Physiology (Imperial College London) MBA (Warwick Business School) MD (University College London) Bachelor of Science in Immunology (University College London) Research Interests: Ashrafian’s work spans: AI in Medicine: Diagnostic algorithms, guideline development (STARD-AI/QUADAS-AI), and ethical frameworks. Metabolic Surgery: Bariatric interventions, gut microbiome, and obesity treatments. Ancient History: Medical analyses of historical figures (e.g., Tutankhamun, Julius Caesar) and art-based pathology identification. Philosophy: AI rights (AIONAI law), temporal paradoxes, and the Simulation Argument. Awards: Royal College of Surgeons Arris and Gale Lectureship Hunterian Prize Wellcome Trust Research Fellowship Advising & Innovation: Supervised >50 PhD students, co-founded Oxford Medical Products (weight loss tech), and serves as CSO at Flagship Pioneering’s Preemptive Health division. He advises on NHS digital transformation and global health policy. Labs/Teams: Leads AI initiatives at Imperial’s Institute of Global Health Innovation and collaborates with Google, NICE, and international institutions on health tech solutions.
Lerrel Pinto is an Assistant Professor of Computer Science at the Courant Institute of Mathematical Sciences at New York University (NYU), where he leads the General-purpose Robotics and AI Lab (GRAIL) as part of the CILVR research group. His work bridges the gap between theoretical machine learning and practical robotics applications, with a focus on enabling robots to generalize and adapt in real-world environments. Dr. Pinto received his undergraduate degree from IIT Guwahati, followed by a PhD from the Robotics Institute at Carnegie Mellon University (CMU). He then completed a postdoctoral fellowship at the University of California, Berkeley before joining NYU as faculty. His research program centers on robot learning and decision making, with several key thrusts that demonstrate his innovative approach to robotics. Pinto's work emphasizes large-scale learning techniques that leverage both extensive data and sophisticated model architectures. A significant portion of his research focuses on representation learning for sensory data, particularly developing methods that enable robots to make sense of visual, tactile, and auditory inputs. His lab has made notable contributions to reinforcement learning algorithms that allow robots to adapt to new scenarios with minimal retraining. Pinto also champions open-source robotics , developing affordable robot platforms that democratize access to robotics research. Analysis of Pinto's recent publications reveals a strong trend toward multimodal perception in robotics, integrating visual, tactile, and auditory information to create more robust robot systems. His work increasingly focuses on zero-shot and few-shot learning capabilities, enabling robots to handle novel situations without extensive retraining. There's also a clear progression toward general-purpose robotics , moving away from task-specific solutions toward more flexible systems that can handle diverse real-world challenges. Dr. Pinto's scientific contributions have been recognized with several prestigious awards: Sloan Research Fellowship (2025) NSF CAREER Award (2024) RAL Early Career Award (2024) Best Student Paper Award at ICRA (2016) Outstanding Paper Award at MFM-EAI workshop at ICML (2024) Best Paper Award at NGSM workshop at ICML (2024) Best Student Paper Award at RSS (2023) As an advisor, Pinto has mentored numerous students who have gone on to impactful careers in both academia and industry. His former PhD student Denis Yarats co-founded Perplexity.AI, while Mahi Shafiullah became a postdoc at UC Berkeley and Meta AI. Many of his Masters students have pursued PhDs at top institutions like CMU, MIT, and Stanford, or joined leading robotics companies including 1X, Fauna Robotics, and NVIDIA. Pinto's lab has secured significant research funding, including the NSF CAREER award and likely other grants supporting his robotics research program. The General-purpose Robotics and AI Lab (GRAIL) that Pinto leads brings together a diverse team of researchers working on cutting-edge robotics challenges. The lab maintains strong collaborations with industry partners and other academic institutions, facilitating technology transfer and real-world impact. GRAIL's research spans multiple robotics platforms and focuses on developing algorithms that enable robots to learn from diverse experiences and generalize across environments.
Didier Trono is a Full Professor at École Polytechnique Fédérale de Lausanne (EPFL), where he leads the Laboratory of Virology and Genetics (LVG) within the School of Life Sciences. Formerly, from 2004 to 2012, he served as the founding dean of EPFL's Faculty of Life Sciences, orchestrating its development and growth during this formative period. Trono received his medical education at the University of Geneva, followed by clinical training in pathology, internal medicine, and infectious diseases in Geneva and at Massachusetts General Hospital in Boston. His scientific career began at the Whitehead Institute of MIT, and in 1990 he was recruited by the Salk Institute of San Diego to launch an AIDS research center. After seven years in the United States, he returned to Europe and eventually joined EPFL. Dr. Trono's research has evolved significantly over his career. Initially focusing on virus-host interactions, he studied pathogens like HIV and Hepatitis B virus, creating HIV-derived genetic transfer tools that are now successfully used in gene therapy. For approximately the last fifteen years, his research has centered on epigenetics, particularly exploring the impact of retroelements and their control mechanisms on development and physiology of higher organisms, including humans. His laboratory investigates how transposable elements and KRAB zinc finger proteins regulate gene expression, with important implications for understanding cancer biology and developing new diagnostic and therapeutic approaches. Analysis of his recent publications (2022-2024) reveals a strong focus on transposable elements, KRAB zinc finger proteins, and their roles in gene regulation and cancer. His work combines molecular biology, genomics, and bioinformatics approaches to understand how these ancient viral remnants have been co-opted by the host genome to regulate development and cellular functions. The research spans basic molecular mechanisms to potential clinical applications in cancer diagnosis and therapy, with some recent work also addressing SARS-CoV-2 and immune responses. Throughout his career, Professor Trono has mentored numerous PhD students, including Bojkowska Karolina, Brandão Sanches Vong Martins Filipe Amândio, Bulliard Yannick, Coluccio Andrea, Corsinotti Andrea, Coudray Alexandre, De Tribolet-Hardy Jonas Caspar, and Dorschel Iris Arianna. His laboratory has received significant funding to support research at the intersection of virology, genetics, and epigenetics, contributing to EPFL's reputation as a leading institution in life sciences research. The Trono Laboratory continues to be at the forefront of research on retroelements and their regulatory mechanisms, maintaining a vibrant research environment that bridges fundamental biological questions with potential medical applications, particularly in cancer research and precision medicine.
Pascal Frossard is a Full Professor at the Department of Electrical Engineering in the School of Engineering (STI) at EPFL, with a courtesy appointment in the School of Computer and Communication Sciences. He founded and directs the LTS4 laboratory since 2003, co-leads the EPFL AI Center and Swiss Data Science Center, and serves as Associate Dean for Research at STI. Research Focus: Machine Learning, Graph Signal Processing, AI Applications in Healthcare, Computer Vision Academic Leadership: IEEE Fellow, ELLIS Fellow, Conference Chair roles Key Projects: Digital Pathology for Oncology, Cardiac Digital Twins, Robust Machine Learning Research Interests: His work bridges signal processing, machine learning, and applied mathematics, emphasizing biomedical applications. Recent research includes adversarial robustness in classifiers, network representation learning, and 360-degree video analysis. Scientific Awards: IEEE Fellow ELLIS Fellow Leadership in IEEE technical committees Advising & Grants: Supervised 20+ PhD students and postdocs. Secured major grants from PHRT, Hasler Foundation, FNS-Sinergia, Armasuisse, Google, and Cisco.
Robert Rohling is a Professor at the University of British Columbia's Faculty of Applied Science, affiliated with the Department of Mechanical Engineering and holding a joint appointment with the Department of Electrical and Computer Engineering. As Director of the Institute of Computing, Information and Cognitive Systems (ICICS), his research focuses on biomedical engineering, medical imaging, robotics, and computational methods. B.A.Sc. (UBC) M.Eng. (McGill) Ph.D. (Cambridge) Rohling's work spans three primary research areas: medical imaging (3D ultrasound, spatial compounding, elasticity reconstruction), medical information systems (radiologist navigation tools for large image datasets), and robotic calibration for surgical applications. His multidisciplinary approach integrates mechanical and electrical engineering principles with clinical needs. Rohling's publications (2020-2022) reveal trends in advanced ultrasound techniques (e.g., shear wave vibro-elastography), AI-driven image processing (cycleGAN translation), and computational optimization for diagnostic accuracy. Keywords across his work include Medical Imaging, Biomedical Engineering, Robotics, and Computational Modeling. As director of the Robotics and Control Laboratory , Rohling leads interdisciplinary collaborations with industry and clinical partners to address practical challenges in medical diagnostics and surgical robotics. His research emphasizes translating engineering innovations into clinical practice.
Harris H. Wang is an Associate Professor in the Department of Systems Biology and Department of Pathology and Cell Biology at Columbia University's Vagelos College of Physicians and Surgeons, where he also serves as Interim Chair of Systems Biology. He is affiliated with the Center for Computational Biology and Bioinformatics (C2B2) and the Integrated Program in Cellular, Molecular and Biomedical Studies (CMBS). B.S., Physics and Mathematics, MIT Ph.D., Biophysics, Harvard University Dr. Wang's research lies at the intersection of systems and synthetic biology, focusing on developing foundational technologies for genome engineering, microbiome manipulation, and synthetic genomics. His lab pioneers methods such as MAGE, MAGIC, CAST, and CAMII to enable high-throughput genetic manipulation, in situ microbiome engineering, and AI-driven microbial culturomics. Key research themes include understanding microbial community dynamics, engineering cellular memory systems, designing biocontained genetic circuits, and applying synthetic biology to human health challenges in personalized medicine and infectious disease. His recent publications reveal a strong trend in spatial and functional metagenomics, CRISPR-based microbiome editing, and synthetic biology tools for data storage and genetic stability. The articles span high-impact journals like Nature , Science , and Nature Biotechnology , reflecting his leadership in developing scalable, programmable biological systems. Scientific Awards: NIH Director’s Early Independence Award Forbes 30 Under 30 in Science Sloan Research Fellowship NSF CAREER Award ONR Young Investigator Award Burroughs Wellcome Fund PATH Award Schaefer Scholar Blavatnik National Award Vilcek Prize PECASE Dr. Wang has advised numerous PhD and postdoctoral researchers, many of whom have gone on to independent scientific careers. His lab is supported by major grants from NIH, NSF, DARPA, DOE, and foundations including the Bill & Melinda Gates Foundation and CZ Biohub NY. He is actively involved in educational initiatives, including organizing Columbia’s iGEM team and the Cold Spring Harbor Laboratory Synthetic Biology course. The Wang Lab is based at the Columbia University Irving Medical Center and is part of national consortia such as the Engineering Biology Research Consortium (EBRC) and the Genome Project-Write (GP-Write) initiative. The lab develops and applies cutting-edge technologies in automation, machine learning, and synthetic biology to engineer microbiomes for applications in medicine, global health, and climate change.
Ameil Joseph is an Associate Professor at McMaster University's School of Social Work, where they contribute to critical scholarship at the intersection of mental health, race, and social justice. Their work examines how ideas about difference, normalcy, sexuality, eugenics, race, ability and mental 'illness' cohere and perform within policy, law and practice, with over a decade of professional experience in mental health settings including supportive housing, settlement services, crisis respite, and forensic community treatment. Education: Ph.D in Social Work, York University (2009-2014) MSW, Wilfrid Laurier University (2005-2007) BA in Psychology, University of Waterloo (1998-2003) Dr. Joseph's research engages with critical mental health, postcolonial theory, critical race theory, and critical disability studies to examine the historical production of ideas about difference. Their scholarship particularly focuses on how these ideas manifest in mental health systems, immigration policy, and criminal justice, with attention to issues of social justice, violence, ethics, and confluence. Their work bridges theoretical frameworks with practical implications, addressing the complex interplay of colonialism, racism, sanism, and eugenics in contemporary social systems. Analysis of Dr. Joseph's recent publications reveals a sustained focus on colonial and eugenic violence within mental health, immigration, and criminal justice systems. Their scholarship consistently examines how racism, sanism, and ableism intersect to produce particular forms of state violence, particularly against racialized immigrants with mental health conditions. Recent work has expanded to address temporal dimensions of oppression, data colonialism, and community responses to grief and loss during the pandemic, demonstrating both theoretical sophistication and practical relevance to current social issues. Scientific Awards: University Scholar 2025 - Recognized for research leadership and impact among eight McMaster professors honored as University Scholars Dr. Joseph has secured significant research funding, including nearly $75,000 from the Social Sciences and Humanities Research Council (SSHRC) for community-engaged projects addressing social justice issues. Their teaching portfolio includes advanced courses on critical mental health perspectives, race and colonialism in Canadian society, and social justice theory. While specific graduate students aren't listed in available materials, their extensive co-author network suggests active mentorship and collaboration. Dr. Joseph contributes to community-based initiatives in Hamilton addressing racism in healthcare and mental health systems, connecting academic scholarship with practical community responses to systemic issues. Dr. Joseph maintains an active presence in community responses to contemporary challenges, particularly through initiatives addressing grief during the pandemic and systemic racism in healthcare. Their work exemplifies the integration of scholarly rigor with community engagement, demonstrating how academic research can inform and be informed by real-world social justice efforts.
Howard A. Stone is the Donald R. Dixon '69 and Elizabeth W. Dixon Professor and Neil A. Omenn '68 University Professor in the Department of Mechanical and Aerospace Engineering at Princeton University's School of Engineering and Applied Science. He leads the Complex Fluids Group, conducting interdisciplinary research at the intersection of engineering, physics, chemistry, and biology. Dr. Stone received his B.S. in Chemical Engineering from UC Davis (1982) and Ph.D. from Caltech (1988). After a postdoctoral year at Cambridge University, he joined Harvard University's faculty in 1989, where he became the Vicky Joseph Professor of Engineering and Applied Mathematics before moving to Princeton in 2009. His research focuses on fluid dynamics phenomena across multiple scales, with particular emphasis on microfluidics, complex fluids, and biomechanics . His group investigates multiphase flows, colloidal systems, bio-inspired fluid phenomena, and physicochemical hydrodynamics. Recent work spans from fundamental studies of thin film drainage and droplet dynamics to applications in biological systems including blood flow, bacterial transport, and biomolecular condensates. The Complex Fluids Group employs experimental, theoretical, and computational approaches, often collaborating with industry partners on applications from medical devices to industrial processes. Analysis of his recent publications reveals a continued expansion into biological applications of fluid dynamics, with increasing focus on cellular mechanics, biomolecular condensates, and pathological hemodynamics, while maintaining strong contributions to fundamental fluid mechanics in complex systems. His work consistently bridges theoretical insights with practical applications across multiple disciplines. Major honors include: Election to the National Academy of Engineering (2009) Election to the National Academy of Sciences (2014) APS Fluid Dynamics Prize (2016) G.K. Batchelor Prize in Fluid Dynamics (2008) NSF Presidential Young Investigator Award Professor Stone has advised numerous PhD students through their Final Public Oral examinations, with recent graduates working on topics spanning microfluidics, bacterial transport, and complex fluid phenomena. His research has been supported by diverse funding sources including NSF, NIH, and industry partnerships. The Complex Fluids Group maintains state-of-the-art experimental facilities in the Engineering Quadrangle, featuring specialized equipment for microfluidics, rheology, and interfacial phenomena investigations. The group actively collaborates with researchers across Princeton and globally, maintaining strong connections to both academic and industrial partners working on fluid-related challenges.
Prof. Marcy Zenobi-Wong is a Full Professor at ETH Zurich's Department of Health Sciences and Technology, specializing in biofabrication and tissue engineering. Her research focuses on cartilage regeneration using advanced biomaterials, including nanofilm coatings and 3D printing techniques. She holds patents in tissue engineering and has pioneered methods like filamented light (FLight) biofabrication for creating anisotropic tissues. Her academic journey includes a B.Sc. from MIT (1985), M.Sc. and Ph.D. from Stanford (1987, 1990), followed by postdoctoral work at the University of Michigan. She leads the Biofabrication Group at ETH, developing therapies for joint repair and regenerative medicine. Courses taught include Biomedical Engineering and Materials and Mechanics in Medicine . Research highlights include engineered hydrogels for cartilage protection, CRISPR-driven gene editing in chondrocytes, and biohybrid neural interfaces. Her work bridges material science, cell biology, and clinical applications, with a focus on translational medicine. Collaborative projects involve creating elastic cartilage grafts for microtia reconstruction and volumetric printing of complex tissue constructs.
Alex Wong is an Assistant Professor of Computer Science at Yale University, specializing in computer vision, robotics, and medical imaging. His research focuses on sensor fusion, unsupervised learning, 3D vision, robust perception under adverse conditions, and medical image analysis. He holds degrees from the University of California, Los Angeles (UCLA), including a B.S., M.S., and Ph.D. in Computer Science. Wong’s work bridges theoretical advances with practical applications, particularly in depth estimation, autonomous systems, and medical diagnostics. He has received prestigious awards such as the NeurIPS Outstanding Student Paper Award (2011) and the ICRA Best Paper Award in Robot Vision (2019). His research often addresses challenges in unstructured environments, emphasizing robustness and adaptability. Recent projects include developing novel frameworks for unsupervised depth completion, adversarial robustness in vision systems, and multimodal fusion techniques. His contributions span conferences like CVPR, ICCV, and ICRA, with a strong focus on advancing AI for real-world applications in healthcare and robotics. Education: B.S., Computer Science, UCLA M.S., Computer Science, UCLA Ph.D., Computer Science, UCLA Awards: NeurIPS Outstanding Student Paper Award (2011) ICRA Best Paper Award in Robot Vision (2019) His lab at Yale Engineering focuses on AI-driven solutions for perception challenges, collaborating across disciplines to advance medical imaging and autonomous systems. Current efforts explore generative models, continual learning, and vision-language integration for robust scene understanding.
Daniel Finley is a Professor of Cell Biology at Harvard Medical School (HMS), leading the Finley Lab focused on the ubiquitin-proteasome pathway and related regulatory mechanisms. He holds academic appointments within the Department of Cell Biology and sits on the Scientific Advisory Boards of Proteostasis and X-Chem Pharmaceuticals. His research investigates proteasome function, ubiquitin-like proteins, and proteostasis roles in diseases like Alzheimer’s and ALS. Dr. Finley earned his undergraduate degree in biochemistry from Harvard University and a Ph.D. in molecular biology from MIT. After postdoctoral training at MIT, he joined HMS in 1988. His lab explores topics including erythroid proteome remodeling, mitochondrial dysfunction, and neurodegenerative disease mechanisms. Key research areas include: (1) Ubiquitin-proteasome pathway regulation, (2) Proteasome structure/function, (3) Nonproteolytic roles of ubiquitination, and (4) Pathophysiological roles of proteostasis defects in diseases. His work bridges basic cell biology with translational medicine, particularly in neurodegeneration and anemia. Finley has secured NIH funding for projects like 'Regulation of Proteasome Activity' (R35GM145246) and 'Erythrocyte maturation through global proteome remodeling' (R01HL153970). Collaborations with industry and academic partners extend his impact in drug discovery and proteasome-targeted therapies. His lab’s contributions include defining ubiquitin chain editing mechanisms, identifying USP14’s role in mitophagy, and elucidating proteostasis defects in Alzheimer's models. Research tools developed include advanced cryo-EM analyses of proteasomal structures and functional assays for ubiquitin system enzymes.
Aisha Ameen is a Researcher in the Department of Veterinary and Animal Sciences (Pathobiological Sciences) at the University of Copenhagen's Faculty of Health and Medical Sciences, holding dual appointments as Research Assistant and Guest Researcher. Her research centers on Alzheimer's disease mechanisms with emphasis on astrocyte metabolism, glucose/glutamate dynamics, and short/medium-chain fatty acid roles. She employs functional metabolic mapping, dMRI, immunohistochemistry, and hiPSC models to investigate neurodegenerative processes at cellular and systemic levels. Analysis of her 2022-2025 publications reveals consistent focus on metabolic dysregulation in Alzheimer's pathology, particularly astrocyte energy substrate competition and fatty acid interventions. Her work bridges neuroscience, metabolism, and translational disease modeling with significant citation impact and media attention.
Brett Welch is an Assistant Professor and Biostatistician at the University of Houston with dual appointments in the Department of Communication Sciences and Disorders and the Department of Psychological, Health, and Learning Sciences within the College of Liberal Arts and Social Sciences. Dr. Welch's educational background includes: Ph.D. in Communication Science and Disorders from the University of Pittsburgh M.S. in Communication Sciences and Disorders from the University of Texas Rio Grande Valley B.S. in Linguistics from the University of Texas at Austin B.A. in Communication Sciences and Disorders – Speech-Language Pathology from the University of Texas at Austin Dr. Welch's research sits at the intersection of psychology and communication. He seeks to understand how psychological processes like personality and psychopathology influence communication behaviors, and conversely, how communication behaviors impact psycho-social well-being. His work leverages quantitative methods, cross-sectional studies, and intensive longitudinal designs to interrogate the dynamic interplay between psychological processes and voice and communication behaviors. This research aims to advance understanding of functional voice disorders, improve assessment of psychopathology, and promote well-being for people with and without communication disorders. Dr. Welch has received several notable awards: Honors Council of Academic Programs in Communication Sciences and Disorders PhD Scholarship (2024) New Century Scholars Doctoral Scholarship from the American Speech-Language-Hearing Foundation (2023) New Investigator Forum from The Voice Foundation (2021) As an academic, Dr. Welch serves as an ad hoc peer reviewer for various scientific journals in speech-language pathology and psychology. He is also a mentor in the Students to Empowered Professional Mentoring Program and a member of the American Speech-Language-Hearing Association. His teaching includes Special Problems: Introduction to Quantitative Modeling (COMD 8398). Dr. Welch maintains an active research program focused on the intersection of psychology and communication, with particular emphasis on voice disorders and their psychological correlates. His work combines biostatistical approaches with clinical insights to advance understanding in this specialized field.
Jonathan W. Friedberg, M.D., M.M.Sc. is the Director of the Wilmot Cancer Institute and Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He holds the Samuel E. Durand Chair in Medicine and leads one of the nation's premier lymphoma programs. Dr. Friedberg is internationally recognized for his expertise in lymphoma treatment, particularly in developing novel therapies and clinical trial approaches. Dr. Friedberg's research focuses on lymphoma, with particular expertise in Hodgkin lymphoma, non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia. His work spans the entire treatment continuum from diagnosis through novel therapies including autologous stem cell transplantation and CAR-T cell interventions. He has built a comprehensive lymphoma program with expertise spanning hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. His research interests include developing risk-adapted treatment strategies, investigating novel therapeutic agents, and improving outcomes for patients with various lymphoma subtypes. Dr. Friedberg's extensive publication record demonstrates his leadership in lymphoma research, with recent work focusing on immunotherapy combinations, predictive modeling, risk stratification, and novel treatment approaches for various lymphoma subtypes. His research has significantly contributed to the understanding and treatment of lymphomas, particularly in developing more personalized and effective treatment strategies. Scientific Awards: Faculty Academic Mentoring Award (2012) Scholar in Clinical Research (2008) America's Top Doctors Selection (2008) Jacob Gitelman Award (2007) Lawrence A. Kohn Senior Teaching Fellow (2004-2006) Clinical Investigator Career Development Award (2003) Clinical Oncology Research Fellowship "Immunotherapy of Hodgkin's Disease" (2001-2003) Rising stars program for innovative research (2001-2003) As Director of the Wilmot Cancer Institute, Dr. Friedberg leads numerous clinical trials and research initiatives focused on advancing lymphoma treatment. He is actively involved in SWOG and has served in leadership roles for multiple clinical trials investigating novel therapies for lymphoma patients. His practice team includes Anna Morrison, R.N., and Kerri Hugelmaier, N.P., providing comprehensive care for lymphoma patients. Dr. Friedberg has established the Lymphoma Epidemiology of Outcomes (LEO) Consortium, a large observational cohort study supporting broad research on NHL prognosis and survivorship. His leadership extends to national organizations where he contributes to developing clinical practice guidelines and consensus recommendations for lymphoma treatment.
